Navigation Links
HYCOR Broadens Diagnostic Offerings, Announces Agreements to License Biomarkers for Celiac Disease and Rheumatoid Arthritis
Date:7/26/2011

GARDEN GROVE, Calif., July 26, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that it has signed an agreement with Eurospital—a manufacturer of pharmaceutical products, medical-surgical and diagnostic devices—to license its tTG biomarker in all countries covered by the patent (excluding the US and Canada) for its ability to diagnose celiac disease. HYCOR today also announced that it has signed an agreement with AXIS-SHIELD—a developer of in vitro diagnostic tests—to license its anti-CCP biomarker for its ability to diagnose rheumatoid arthritis (RA). Customers will have access to these critical biomarkers from HYCOR in the coming weeks.

"We are pleased to offer HYCOR customers a tool to help clinicians diagnose these devastating, chronic diseases," said Dick Aderman, CEO, HYCOR. "We look forward to continuing to expand our diagnostic offerings, ensuring customers are able to meet the ever-changing needs of the healthcare professionals they serve."

Celiac disease is a condition that damages the lining of the small intestine and prevents it from absorbing nutrients properly, leading to malnutrition. The symptoms of celiac disease vary from one patient to the next, which poses challenges to healthcare professionals in the accurate diagnosis of the disease. If left untreated celiac disease can cause other complications, including autoimmune disease, anemia and hypoglycemia, and, in some instances, certain types of intestinal cancer.(i)

RA is a chronic autoimmune disease that leads to joint inflammation, as well as inflammation of the surrounding tissue. Early diagnosis of the disease, and early aggressive treatment, can delay joint destruction and prevent symptoms from worsening.(ii)

About HYCOR Biomedical, Inc.

Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets the HYTEC™, KOVA® and AUTOSTAT™ brands. The company is focused on delivering products that provide the highest value to clinicians through innovation, reliability and customer service. For more information, please visit www.hycorbiomedical.com.

About Eurospital

Founded in 1948, Eurospital is a scientific organization active in such sectors as diagnostics, pharmaceutical industry and hospital practice. The Company is located in Trieste (ITALY), a city hosting a number of international research centers, which are now gaining increasing scientific importance in the field of biotechnology. The company is focused on the diagnosis of celiac diseases, gastroenterology, infectious diseases, septic infections.

About AXIS-SHIELD

Axis-Shield (www.axis-shield.com) is an international and innovative in vitro diagnostics company, headquartered in Dundee with R&D and manufacturing bases in Dundee and Oslo. The Group specializes in the supply of instruments and tests for the rapidly growing physician's office testing market and the development, manufacture and marketing of innovative proprietary diagnostics kits in areas of clinical need, including cardiovascular and neurological diseases, rheumatoid arthritis, and diabetes.

(i) PubMed Health, available at http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001280/, accessed July 15, 2011

(ii) PubMed Health, available at http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001467/, accessed July 15, 2011


'/>"/>
SOURCE HYCOR Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HYCOR Appoints Sean-Xavier Neath as Chief Medical Officer to Support Expansion of Product Lines and Enhance Customer Support Offerings
2. HYCOR Expands Board of Directors to Support Growth in Key Areas
3. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
4. United Spinal Association Broadens Its Reach with Users First: Giving Voice to All Wheelchair Users
5. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
6. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
7. FDA Broadens Clearance for Agendias MammaPrint(R)
8. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
9. BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman
10. Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
11. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... and Markets has announced the addition of the "Hemophilia Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Hemophilia ... market? What are the unit prices and annual treatment ...
(Date:2/24/2017)... 24, 2017 Medical information groups within ... their self-service capabilities to manage inquiries from external ... New research from consulting leader Best Practices, ... self-service website portals where HCPs can sign on ... of many findings to emerge from the new ...
Breaking Medicine Technology:
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... Philadelphia, PA (PRWEB) , ... February 26, 2017 , ... ... products and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for ... , Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
Breaking Medicine News(10 mins):